Related Experiment Video
Updated: May 3, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Basic data related to thrombolytic therapy for acute venous thrombosis
Tina T Ng1, Michael Sigman1, Fred A Weaver1
1Division of Vascular Surgery and Endovascular Therapy, USC Cardiovascular Thoracic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Insights
Current treatment guidelines for iliofemoral deep venous thrombosis (DVT) lack robust data. This review summarizes existing evidence on catheter-directed thrombolysis (CDT) and pharmacomechanical thrombectomy to inform future DVT management strategies.
Area of Science:
- Vascular Medicine
- Interventional Cardiology
- Thrombosis Research
Background:
- Treatment guidelines for iliofemoral deep venous thrombosis (DVT) are based on limited observational and prospective studies.
- The ATTRACT trial is the first large, multicenter randomized control trial for iliofemoral DVT treatment strategies.
- Existing data on catheter-directed thrombolysis (CDT) and pharmacomechanical thrombectomy for acute iliofemoral DVT are limited.
Purpose of the Study:
- To summarize existing data informing the use of catheter-directed thrombolysis (CDT) or pharmacomechanical thrombectomy.
- To provide a foundation for understanding current treatment strategies in acute iliofemoral DVT.
- To contextualize the upcoming results from the ATTRACT trial.
Main Methods:
- A comprehensive literature search was conducted using PubMed, Ovid, and Cochrane databases.
- Searched for articles published up to December 2013.
- Included studies with at least 25 patients, case series, national registry data, and randomized control trials.
Main Results:
- Nineteen case series (1996-2012) and three national registry studies were identified.
- Treatment modalities included anticoagulation, surgical thrombectomy, pharmacomechanical thrombectomy, and CDT.
- Only two randomized control trials (2002-2012) were found, both supporting CDT over anticoagulation alone for iliofemoral DVT.
Conclusions:
- Current treatment guidelines for acute iliofemoral DVT are based on limited clinical data.
- The evidence base for CDT and pharmacomechanical thrombectomy in iliofemoral DVT requires further robust investigation.
- This summary anticipates the findings of the ongoing ATTRACT trial to refine DVT treatment guidelines.
Background:
Treatment guidelines for thrombolysis in iliofemoral deep venous thrombosis (DVT) are based on a limited number of observational and prospective studies. The acute venous thrombosis: thrombus removal with adjunctive catheter-directed thrombolysis (ATTRACT) trial will be the first large, multicenter randomized control trial to evaluate the relative advantages of several current treatment strategies. The objective of this study was to summarize the existing data that inform the use of catheter-directed thrombolysis (CDT) or pharmacomechanical thrombectomy in the management of acute iliofemoral DVT.
Methods:
A search of the current literature was done using PubMed, Ovid, and Cochrane databases for all available articles published up to December 2013.
Results:
Of those studies, which included at least 25 patients, 19 case series were identified from 1996 to 2012. Treatment groups included anticoagulation, surgical thrombectomy, pharmacomechanical thrombectomy, and CDT. Cases observed in each ranged from 26 to 101. Three studies were identified which derived data from national multicenter registries. Only 2 randomized control trials were identified from 2002 to 2012. Both support the use of CDT over anticoagulation alone for treatment of iliofemoral DVT.
Conclusions:
Present treatment guidelines for acute iliofemoral DVT have been in flux and are derived from a relatively small amount of clinical data. They are summarized here in anticipation of results from the ongoing ATTRACT trial.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

